MARKET

VRNA

VRNA

Verona Pharma
NASDAQ
66.27
+0.18
+0.27%
After Hours: 66.34 +0.07 +0.11% 19:06 03/20 EDT
OPEN
65.78
PREV CLOSE
66.09
HIGH
67.38
LOW
65.03
VOLUME
542.82K
TURNOVER
--
52 WEEK HIGH
70.40
52 WEEK LOW
11.39
MARKET CAP
5.63B
P/E (TTM)
-31.1595
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at VRNA last week (0310-0314)?
Weekly Report · 3d ago
Verona Pharma: Great Year For Share Price, But Competition Threatens Bull Thesis
Seeking Alpha · 03/13 17:26
Weekly Report: what happened at VRNA last week (0303-0307)?
Weekly Report · 03/10 10:13
Verona Pharma management to meet with Truist
TipRanks · 03/07 16:06
BTIG Sticks to Its Buy Rating for Verona Pharma (VRNA)
TipRanks · 03/05 10:29
Verona Pharma management to meet with Piper Sandler
TipRanks · 03/03 15:02
Beat the Market the Zacks Way: Verona, Visa, Starbucks in Focus
NASDAQ · 03/03 13:08
Weekly Report: what happened at VRNA last week (0224-0228)?
Weekly Report · 03/03 10:12
More
About VRNA
Verona Pharma Plc is a United Kingdom-based biopharmaceutical company. The Company is focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. Its product candidate, ensifentrine, is an investigational, inhaled, small molecule and dual inhibitor of the enzyme’s phosphodiesterase 3 and 4 (PDE3 and PDE4) combining bronchodilator and non-steroidal anti-inflammatory activities in one compound. It is engaged in developing inhaled ensifentrine for the treatment of chronic obstructive pulmonary disease (COPD). The Company's two additional formulations of ensifentrine are in Phase II development for the treatment of COPD: dry powder inhaler (DPI) and pressurized metered-dose inhaler (pMDI). The Company's wholly owned subsidiary is Verona Pharma, Inc.

Webull offers Verona Pharma PLC - ADR stock information, including NASDAQ: VRNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VRNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VRNA stock methods without spending real money on the virtual paper trading platform.